Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that its wholly owned U.S. subsidiary, American CHM Investments Inc., has signed a letter of intent (LOI) to partner with Applied Cannabis Sciences of New Jersey, a New Jersey-based medical retail dispensary applicant in the upcoming New Jersey round of request of applications (RFA), which is anticipated in 2020.
Applied Cannabis Sciences has been established by a team of seasoned professionals from the legal medicinal & adult use marijuana industry whose collective experience exceeds 50 years and includes over 20 cultivation, processing, ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.